Kura Oncology Inc
(FRA:KUR)
€
9.84
-0.56 (-5.38%)
Market Cap: 850.09 Mil
Enterprise Value: 361.38 Mil
PE Ratio: 0
PB Ratio: 8.98
GF Score: 36/100 Kura Oncology Inc at Barclays Global Healthcare Conference Transcript
Mar 15, 2022 / 03:15PM GMT
Release Date Price:
€13.2
(-12.00%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst
There we go. So I just wanted to thank everybody for attending fireside chat with Kura, attending a conference in Miami. So very grateful everyone came down, and I hope everyone is feeling, feeling great. And hopefully, their meetings are going well. And my name is Peter Lawson. I'm hosting this fireside chat with Kura. So I am one of biotech analysts here. I just want to thank Troy Wilson, CEO from Kura, for coming down and support as well and been in person for our conference. So it's really exciting after 2 years has been at home and back in person again, thankfully.
Questions & Answers
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst
So first question, I guess, kind of the differentiation of Kura in the oncology space or maybe you want to cover kind of a company overview and just a few seconds on that.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot